发明名称 |
Recombinant modified vaccinia virus Ankara influenza vaccine |
摘要 |
The invention concerns a recombinant modified vaccinia virus Ankara (MVA virus) expressing at least two external influenza virus antigens and/or an epitope of one or more of the at least two antigens and at least two internal influenza virus antigens and/or an epitope of the at least two antigens. The invention, thus, concerns a recombinant MVA virus encoding multiple external and/or internal influenza virus antigens, preferably from multiple influenza virus strains. The invention further concerns the use of said recombinant MVA in preparing a medicament and vaccine for influenza virus. Further encompassed by the present invention are methods, composition and kits. |
申请公布号 |
US9173933(B2) |
申请公布日期 |
2015.11.03 |
申请号 |
US201113877218 |
申请日期 |
2011.10.07 |
申请人 |
BAVARIAN NORDIC A/S |
发明人 |
Weigl Josef;Hausmann Jürgen;Steigerwald Robin |
分类号 |
A61K39/275;A61K39/145;C12N15/86;A61K39/12;A61K39/00 |
主分类号 |
A61K39/275 |
代理机构 |
Law Office of Salvatore Arrigo and Scott Lee, LLP |
代理人 |
Law Office of Salvatore Arrigo and Scott Lee, LLP |
主权项 |
1. A modified vaccinia virus Ankara (MVA) comprising at least 11,000 nucleotides of influenza nucleic acid sequences encoding at least 5 external influenza virus antigens and at least 3 internal influenza virus antigens, wherein the nucleic acid sequences encoding the antigens are inserted into at least two MVA insertion sites,
wherein the external influenza virus antigens comprise at least 3 different hemagglutinin antigens selected from hemagglutinin 2 (H2), hemagglutinin 9 (H9), hemagglutinin 5 (H5), and hemagglutinin 7 (H7) antigens. |
地址 |
Kvistgaard DK |